Navigation Links
Transonic sponsors Flow Measurement workshop at 9th Annual Scientific meeting of the Society of Diagnostic and Interventional Nephrology
Date:2/13/2013

(PRWEB) February 13, 2013

Transonic Systems will be exhibiting at the 9th Annual Scientific Meeting of the American Society of Diagnostic and Interventional Nephrology (ASDIN), to be held in Washington, D.C., on February 15th – 17th, 2013. ASDIN is one of the fastest growing medical societies in the US, and approximately 500 physicians who specialize in vascular access procedures are expected at the 2013 meeting.

The mission of the American Society of Diagnostic and Interventional Nephrology is to promote the appropriate application of new and existing procedures in order to improve the care of patients with kidney disease. The Society promotes education, research, public policy and clinical practice initiatives relating to diagnostic and interventional procedures. ASDIN works closely with other societies and programs to achieve its goals. Transonic is pleased to partner with ASDIN to assist in the promotion of techniques which improve the outcomes of End Stage Renal Disease patients.

For the second consecutive year, ASDIN will also be offering an Advanced Techniques Pre-Course in conjunction with the Scientific Sessions. The full day Pre-Course, which is limited to 80 registrants, will include a series of advanced presentations in the morning, followed by a series of hands-on workshops in the afternoon. Transonic will be offering a Flow Measurement workshop with the HVT100 Endovascular Flowmeter and ReoCath catheters, for use in interventional access procedures and minimally invasive fistula banding procedures for the treatment of Dialysis Associated Steal Syndrome, a potentially severe complication where blood supply to the hand and fingers is restricted. Dr. Gregg Miller, of Brooklyn, New York, will be instructing 80 physicians on the flow assisted Miller Technique (Minimally Invasive Limited Ligation Endoluminal-Assisted Revision) for endovascular banding of high flow fistulas, to treat Steal Syndrome. The Transonic OptiMax flow probe for flow assessment during fistula creation and open banding procedures will also be demonstrated to the workshop participants. Flow assessment during access creation helps ensure functional success of the fistula or graft.

Among the presentations at this year’s meeting, several scientific papers feature the use of access blood flow measurement with the HVT100 Endovascular Flowmeter and ReoCath catheters to help optimize clinical outcomes. Dr. Gregg Miller of American Access Care, Brooklyn NY will present on the “Management of Access Flows to Address Steal, Cardiovascular Compromise, and Arm Swelling.” Dr. Thomas Vesely of St. Louis Vascular Access will discuss “Fundamentals of Arterial and Venous PTA”. Finally, Dr. Dirk Hentschel of Brigham and Women’s Hospital in Boston, MA will present on the “Recognition and Diagnosis of High-Flow Fistula”

Read the full story at http://www.prweb.com/releases/2013/2/prweb10426172.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Aviir Sponsors Eco Hideaway 2013 Music Artist Stage At The Chateaux In Park City, Utah To Benefit Heart Disease
2. Caris Sponsors CancerCare Connect Education Workshop on Molecular Profiling in the Treatment of Breast Cancer
3. Pinnaclife Sponsors "The Prevent Event: Breast Cancer Education And You!"
4. Janssen Research & Development, LLC, Sponsors First of its Kind Research Initiative to Advance Multiple Sclerosis Science
5. APCER Pharma Sponsors Major Industry Conference
6. Cambridge Healthtech Associates™ Co-Sponsors BIO Debrief Networking Reception with Xconomy
7. Aviir Diagnostics Laboratory in Collaboration with Cause;ology Sponsors "Storyland," a Red Carpet Charity Extravaganza in Hollywood
8. ActiGraph Announces Heart Rate Variability Measurement Support
9. NISTs nanotubes on a chip may simplify optical power measurements
10. Europe Anesthesia and Respiratory Devices Market Outlook to 2018 - Respiratory Devices, Respiratory Measurement Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others
11. Islet Sciences Announces Exclusive License Agreement with Winthrop University Hospital to Commercialize a Beta Cell Loss Measurement Technology in Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
(Date:2/16/2017)... and NEW YORK , Feb. 16, ... completion of their $7M Series B financing, adding an ... the $3.5M led by Mesa Verde Venture Partners and ... resources will be directed towards further accelerating commercial adoption ... comprehensive genomic profiling test and expanding the Paradigm cancer ...
(Date:2/15/2017)... , 15. Februar 2017  Trianni, Inc. ... Biotech, Inc. (Janssen) eine Lizenzvereinbarung über die Verwendung ... Klasse führenden Plattform für die Entdeckung monoklonaler Antikörper. ... ihr neuartiges chimäres Gensegmentdesign aus, das Janssen ... humanen Antikörpern bietet und das für die schelle ...
(Date:2/15/2017)... -- Windtree Therapeutics, Inc. (Nasdaq: WINT ), ... therapies for respiratory diseases, will host a conference call ... EST on Thursday, February 16, 2017 to provide updates ... announced closing of a $10.5 million private offering and ... in the live call and take part in the ...
Breaking Biology Technology:
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:2/2/2017)... , Feb. 1, 2017  Central to its ... meaningful advances worldwide, The Japan Prize Foundation today ... who have pushed the envelope in their respective ... Communication. Three scientists are being recognized with the ... that not only contribute to the advancement of ...
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
Breaking Biology News(10 mins):